NCT01045421
- Conditions
- Advanced Nonhematological Malignancies, Breast Diseases, Breast Neoplasms, +24 more
- Locations
-
- Houston, Texas, United States
- Salt Lake City, Utah, United States
Clinical trial condition
Gastroesophageal Adenocarcinoma
Explore clinical trials studying Gastroesophageal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
25 public trials
14 recruiting studies
Gastroesophageal Adenocarcinoma trial results
Completed
Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer
NCT00073502
- Conditions
- Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma
- Locations
-
- University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States
- University of Utah, Huntsman Cancer Institute Salt Lake City, Utah, United States
- Dept Internal Medicine Gastrointestinal Oncology Unit B-3000 Leuven, Belgium
Active, Not Recruiting
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
NCT05152147
- Conditions
- Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +13 more
- Locations
-
- Hospital de Gastroenterología Dr Bonorino Udaondo Buenos Aires, Argentina
- Instituto de Investigaciones Metabólicas - IDIM Buenos Aires, Argentina
- Hospital Italiano de Buenos Aires Buenos Aires, Argentina
- Fundación Centro de Medicina Nuclear y Molecular ER Córdoba, Argentina
Active, Not Recruiting
Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
NCT04021108
- Conditions
- Gastroesophageal Adenocarcinoma
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Washington University School of Medicine St Louis, Missouri, United States
- University of Nebraska Omaha, Nebraska, United States
- Roswell Park Cancer Center Buffalo, New York, United States
Active, Not Recruiting
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab
NCT05029882
- Conditions
- Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +20 more
- Locations
-
- University of California, Los Angeles /ID# 243841 Los Angeles, California, United States
- University Of Colorado Denver /ID# 231574 Aurora, Colorado, United States
- Yale School of Medicine /ID# 248418 New Haven, Connecticut, United States
- University of Illinois Hospital and Health Sciences System /ID# 251386 Chicago, Illinois, United States